The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial (BMC Infectious Diseases)

21 october 2020 17:07:22

Coronavirus disease 2019 (COVID-19) has infected people in many countries worldwide. Discovering an effective treatment for this disease, particularly in severe cases, has become the subject of intense scienti...

316 viewsCategory: Immunology, Pathology

Risk conditions in children hospitalized with influenza in Norway, 2017–2019 (BMC Infectious Diseases)
Oral beta-lactam step down in bacteremic E. coli urinary tract infections (BMC Infectious Diseases)

blog comments powered by Disqus

MyJournals.org
The latest issues of all your favorite science journals on one page

The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial (BMC Infectious Diseases)

21 october 2020 17:07:22

Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice. Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten

Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten